Recent Finacing
Recent Raise
Frequency Therapeutics is a clinical-stage biotechnology company that develops small-molecule therapies using its Progenitor Cell Activation platform to activate progenitor cells and regenerate tissues, including FX-322 for sensorineural hearing loss.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
